PDUFA Date
RARE: PDUFA Date: dtx401 aav gene therapy
August 23, 2026 · dtx401 aav gene therapy. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- August 23, 2026
- Company
- Ultragenyx Pharmaceutical Inc. (RARE)
- Drug
- dtx401 aav gene therapy
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
PDUFA Date
PDUFA Date: dtx401 aav gene therapy
- Drug
- dtx401 aav gene therapy
- Indication
- Glycogen Storage Disease Type Ia (GSDIa)